Fatma Akyel
Fatma Akyel has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ayhan Kars
Otolaryngology Department, Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital, Erzincan, Türkiye
1 shared publication - Fatma Atalay
Kastamonu University, Turkey
1 shared publication - Fatma Mutlu Kukul Güven
Kastamonu Üniversitesi
1 shared publication - Hatice Karabulut1 shared publication
- Korhan Kilic
Department of Otorhinolaryngology, Atatürk University Faculty of Medicine, Erzurum, Turkey
1 shared publication - Kübra Topal
Private Otorhinolaryngology Clinic, Kastamonu, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (3) , 579-585
Exploring vestibular dysfunction in primary hypothyroidism using cervical vestibular evoked myogenic potentials
Purpose: This research was conducted to assess cervical vestibular evoked myogenic potential (cVEMP) test responses in patients with primary hypothyroidism without vestibular symptoms. Materials and Methods: Thirty-one patients diagnosed with primary hypothyroidism and who had not yet started on hormone replacement therapy, together with a 26-member control group, were enrolled in the research. All participants underwent detailed otorhinolaryngological examinations and thyroid function, cVEMP, and audiological tests. cVEMP records were compared between the groups. Results: Thirty-one patients aged between 21 and 57 years (38.5±9.7) and a control group of 26 healthy volunteers aged between 20 and 52 years (36.1±8.8) were included in the study. Absent VEMP responses were observed in 12 members of the patient group and in three of the control group. Interpeak amplitudes (IPAs) in both ears were significantly lower in the patient group than in the controls. While no significant difference was found between the groups’ VEMP threshold values, asymmetry rates in both ears were significantly higher in the patient group. Conclusion: cVEMP can be usefully employed in the detection of subclinical
- 30 September 2025
- Published by Cukurova Medical Journal in Cukurova Medical Journal
- Vol. 50 (3) , 579-585
Open AccessExploring vestibular dysfunction in primary hypothyroidism using cervical vestibular evoked myogenic potentials
Purpose: This research was conducted to assess cervical vestibular evoked myogenic potential (cVEMP) test responses in patients with primary hypothyroidism without vestibular symptoms. Materials and Methods: Thirty-one patients diagnosed with primary hypothyroidism and who had not yet started on hormone replacement therapy, together with a 26-member control group, were enrolled in the research. All participants underwent detailed otorhinolaryngological examinations and thyroid function, cVEMP, and audiological tests. cVEMP records were compared between the groups. Results: Thirty-one patients aged between 21 and 57 years (38.5±9.7) and a control group of 26 healthy volunteers aged between 20 and 52 years (36.1±8.8) were included in the study. Absent VEMP responses were observed in 12 members of the patient group and in three of the control group. Interpeak amplitudes (IPAs) in both ears were significantly lower in the patient group than in the controls. While no significant difference was found between the groups’ VEMP threshold values, asymmetry rates in both ears were significantly higher in the patient group. Conclusion: cVEMP can be usefully employed in the detection of subclinical
- 21 June 2022
- Published by MediHealth Academy
- p. 54-56
Multiorgan dysfunction due to colchicine
Colchicine is used in the treatment of many diseases. It should be used very carefully as the treatment dose and toxic dose are very close to each other and may lead to multiorgan failure. Although colchicine toxicity is usually seen in suicidal use, it may also occur when used in therapeutic doses. In this report, we present a case of a 70-year-old patient who used colchicine due to pericardial effusion over two months and died from multiorgan failure, to draw attention to colchicine toxicity due to using it in therapeutic doses.
- 21 June 2022
- Published by MediHealth Academy
- p. 54-56
Multiorgan dysfunction due to colchicine
Colchicine is used in the treatment of many diseases. It should be used very carefully as the treatment dose and toxic dose are very close to each other and may lead to multiorgan failure. Although colchicine toxicity is usually seen in suicidal use, it may also occur when used in therapeutic doses. In this report, we present a case of a 70-year-old patient who used colchicine due to pericardial effusion over two months and died from multiorgan failure, to draw attention to colchicine toxicity due to using it in therapeutic doses.